retatrutide phase 3 2025 triple agonist glp-1 gip glucagon (Eli Lilly's GLP-1/GIP/Glucagon receptor agonist) just delivered the most impressive obesity + osteoarthritis data we've ever seen in the TRIUMPH-4 trial: What Is Retatrutide? The Triple

Description

The metabolic defense mechanisms that had been suppressed by GLP-1 agonism reengaged fully

Research Use Only Our products are intended exclusively for use in laboratories, universities, and by qualified independent researchers

5 nmol kg 1

Both medications contain the same semaglutide

Neither program guarantees that a specific medication will be prescribed

In a study investigated whether miRNAs affect GLP-1's glucose-stimulated insulin release, authors measured miRNA levels in rat insulinoma cell line (INS-1) cells and isolated islets from GLP-1-treated rats and humans using osmotic pumps in vitro and in vivo